Revlimid and Atrioventricular block complete - a phase IV clinical study of FDA data
Summary:
Atrioventricular block complete is reported as a side effect among people who take Revlimid (lenalidomide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have High blood pressure.
The phase IV clinical study analyzes which people have Atrioventricular block complete when taking Revlimid. It is created by eHealthMe based on reports of 377,717 people who have side effects when taking Revlimid from the FDA, and is updated regularly.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.
What is Atrioventricular block complete?
Atrioventricular block complete (heart block complete) is found to be associated with 671 drugs and 950 conditions by eHealthMe. Check the latest studies of Atrioventricular block complete.
377,717 people reported to have side effects when taking Revlimid.
Among them, 91 people (0.02%) have Atrioventricular block complete.

Among these 91 people:
How long have people been on Revlimid when they have Atrioventricular block complete? *
- < 1 month: 35.71 %
- 1 - 6 months: 42.86 %
- 6 - 12 months: 10.71 %
- 1 - 2 years: 7.14 %
- 2 - 5 years: 3.57 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Atrioventricular block complete when taking Revlimid? *
- female: 31.4 %
- male: 68.6 %
What is the age of people who have Atrioventricular block complete when taking Revlimid? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 1.28 %
- 30-39: 0.0 %
- 40-49: 1.28 %
- 50-59: 1.28 %
- 60+: 96.15 %
What are other drugs people take besides Revlimid? *
- Zometa: 31 people, 34.07%
- Aspirin: 30 people, 32.97%
- Lasix: 29 people, 31.87%
- Folic Acid: 26 people, 28.57%
- Cozaar: 26 people, 28.57%
- Valtrex: 26 people, 28.57%
- Compazine: 25 people, 27.47%
- Allopurinol: 24 people, 26.37%
- Xanax: 24 people, 26.37%
- Piroxicam: 24 people, 26.37%
What are other side effects people have besides Atrioventricular block complete? *
- Fatigue (feeling of tiredness): 28 people, 30.77%
- Fainting (loss of consciousness and postural tone): 28 people, 30.77%
- Bradycardia (abnormally slow heart action): 26 people, 28.57%
- Dyspnea (difficult or laboured breathing): 26 people, 28.57%
- Diarrhea: 26 people, 28.57%
- Cough: 26 people, 28.57%
- Thrombocytopenia (decrease of platelets in blood): 25 people, 27.47%
- Chest Pain: 25 people, 27.47%
- Cardiac Murmur (an heart sound in valve abnormality): 25 people, 27.47%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 25 people, 27.47%
What are the existing conditions these people have? *
- High Blood Pressure: 29 people, 31.87%
- Mood Swings (an extreme or rapid change in mood): 24 people, 26.37%
- Diarrhea: 24 people, 26.37%
- Joint Pain: 24 people, 26.37%
- High Blood Cholesterol: 24 people, 26.37%
- Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 24 people, 26.37%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 24 people, 26.37%
- Seasonal Allergy (allergic condition due to certain season): 18 people, 19.78%
- Blood Triglycerides Decreased: 18 people, 19.78%
- Nausea (feeling of having an urge to vomit): 4 people, 4.40%
* Approximation only. Some reports may have incomplete information.
Do you take Revlimid and have Atrioventricular block complete?
- Check whether Atrioventricular block complete is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Revlimid:
- Revlimid (378,026 reports)
Atrioventricular block complete treatments and more:
- Atrioventricular block complete (9,036 reports)
How severe was Atrioventricular block complete and when was it recovered:
Expand to all the drugs that have ingredients of lenalidomide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Atrioventricular block complete:
- Atrioventricular block complete (671 drugs)
Browse all the conditions that are associated with Atrioventricular block complete:
- Atrioventricular block complete (950 conditions)
Related publications that referenced our studies
- Min IS, Lee JY, Jung TS, Kang NK, Park BB, Kim BK, "Development of a Complete Atrioventricular Block Associated with Intake of Evening Primrose Oil", The Korean Journal of Medicine, 2016 May .
- Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .
- Min IS, Lee JY, Jung TS, Kang NK, Park BB, Kim BK, "Development of a Complete Atrioventricular Block Associated with Intake of Evening Primrose Oil", The Korean Journal of Medicine, 2016 May .
- Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Genvoya and Lactulose - now
- Drug interactions of Candesartan Cilexetil and Cefazolin Sodium - 2 seconds ago
- Drug interactions of Ondansetron Hydrochloride and Pantoprazole - 16 seconds ago
- Drug interactions of Fycompa and Hydrochlorothiazide - 18 seconds ago
- Drug interactions of Levoxyl and Lysine - 19 seconds ago
- Hair Loss and Skin - Clammy - 27 seconds ago
- Cranberry Extract vs. Ceftin, side effect and effectiveness comparison - 30 seconds ago
- Could Colofac cause Fatigue? - 34 seconds ago
- Could Bethkis cause Coughing Up Blood? - 45 seconds ago
- Drug interactions of Clopidogrel and Phyllocontin - 45 seconds ago